• Skip to main content
  • Skip to primary sidebar
  • Skip to footer

33 Charts

  • About
    • What is 33 Charts?
    • Bryan Vartabedian MD
  • Blog
  • 33mail
  • Foci
    • Social/Public Media
    • Physicians
    • Patients
    • Hospitals
    • Information
    • Process/Flow
    • Technology
    • Digital culture
    • Future Medicine
  • The Public Physician
Patients, Technology

23andMe – Why Our Big Government is Right

November 28, 2013 By Bryan Vartabedian · Reading Time: < 1 minutes

imgresThis week our big government stuck its imposing finger in the eye of the self-empowered populous.  The FDA shuttered personal genomics company 23andMe until it could come up with evidence that their reports mean anything.

The response of the American consumer has been muted.  In fact, I’m not sure the average 23andMe user is concerned with what the fuss is all about.  Experiences with my closest friends who have undergone analysis involve a measured balance of shock and amusement that seems to approximate the response of someone reading a horoscope.  Actionable stories exist.

23andMe embodies a generation preoccupied with itself.  Our right to know has superseded our ability to understand.  Empowerment has evolved as data, information, knowledge and wisdom are almost seen as one in the same.  Whether 23andMe’s reporting is actionable is to miss the point.  When you’ve got your data, what more do you need, really?  Epigenetics…what epigenetics?

As one predisposed to a free market thinking in the area of health disruption, I’m less inclined to come down on the side of a meddling government.  But here the FDA is advocating for a public (as well as a desperately undereducated medical community) that lacks the capacity to understand that good data visualization doesn’t always equate to good health information.

Self-determination is the rage and no technolibertarian wants to be told what they can or can’t do with respect to their health.  But things that were once out of fashion have a way of coming back.  Big government regulation may have a future in patient empowerment.

And who said paternalism is dead?

For more on this, check out the ever-brilliant Matthew Herper and his take in Forbes, 23andStupid.

Related Articles

  • Should Doctors Google Their Patients?
  • 23andMe and a Doctor’s Control
  • Why IBM Watson is Important

Related Articles

  • Should Doctors Google Their Patients?
  • 23andMe and a Doctor’s Control
  • Why IBM Watson is Important

Primary Sidebar

Bryan Vartabedian, MD

Bryan Vartabedian, MD
Bryan Vartabedian is the Chief Pediatrics Officer at Texas Children’s Hospital North Austin and one of health care’s influential
voices on technology & medicine.
Learn More

Popular Articles

  • The Fate of Fired Cleveland Clinic Resident Lara Kollab
  • Cures Act Final Rule – How It Will Change Medicine
  • 12 Things About Doximity You Probably Didn’t Know
  • Should Physicians Give Their Cell Phone Number to Patients?
  • Doximity Dialer Video – Telemedicine’s Latest Power Player

Sign up for 33mail newsletter

Featured Articles

100,000 Connected Lemmings

The Rise of Medicine’s Creative Class

Doctors and social media: Damned if you engage, damned if you don’t

The Case for New Physician Literacies in the Digital Age

Will the Future Need Doctors?

  • Facebook
  • LinkedIn
  • Twitter

Footer

What is 33 Charts?

With a mashup of curated and original content that crosses the spaces of digital health, media, communication, technology, patient experience, digital culture, and the humanities, 33 charts offers unique insight and analysis on the changing face of medicine.

Founded in 2009 as a center of community and thought leadership for the issues doctors face in a digital world, 33 charts was included in the National Library of Medicine permanent web archive in 2014.
Learn More

Foci

  • Digital culture
  • Digital Health
  • EHR/Health IT
  • Future Medicine
  • Hospitals
  • Information
  • Patients
  • Physicians
  • Process/Flow
  • Quality
  • Social/Public Media
  • Technology

Copyright © 2023 · 33 Charts · Privacy Policy